Compare DXCM & CG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DXCM | CG |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5B | 21.2B |
| IPO Year | 2005 | N/A |
| Metric | DXCM | CG |
|---|---|---|
| Price | $58.89 | $49.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | ★ $85.33 | $66.43 |
| AVG Volume (30 Days) | ★ 4.5M | 3.2M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | ★ 47.18 | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.46 | $16.70 |
| Revenue Next Year | $12.31 | $16.17 |
| P/E Ratio | $118.88 | ★ $25.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $54.11 | $43.19 |
| 52 Week High | $89.07 | $69.85 |
| Indicator | DXCM | CG |
|---|---|---|
| Relative Strength Index (RSI) | 39.27 | 50.16 |
| Support Level | $56.72 | $45.59 |
| Resistance Level | $60.85 | $54.62 |
| Average True Range (ATR) | 2.07 | 2.24 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 28.53 | 47.55 |
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Carlyle Group is one of the world's largest alternative-asset managers, with $474.1 billion in total AUM, including $332.0 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, which includes its private equity, real estate, infrastructure, and natural resources offerings (with $163.5 billion in total AUM and $101.1 billion in fee-earning AUM), global credit ($208.5 billion/$167.2 billion), and investment/fund solutions, known as Carlyle AlphInvest ($102.1 billion/$63.7 billion). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 3,100 active carry fund investors from 87 countries.